These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 3280741

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.
    Machover D, Goldschmidt E, Chollet P, Metzger G, Zittoun J, Marquet J, Vandenbulcke JM, Misset JL, Schwarzenberg L, Fourtillan JB.
    J Clin Oncol; 1986 May; 4(5):685-96. PubMed ID: 3517242
    [Abstract] [Full Text] [Related]

  • 3. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma.
    Petrelli N, Herrera L, Rustum Y, Burke P, Creaven P, Stulc J, Emrich LJ, Mittelman A.
    J Clin Oncol; 1987 Oct; 5(10):1559-65. PubMed ID: 2443619
    [Abstract] [Full Text] [Related]

  • 4. 5-Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer: a randomized comparison. A Southwest Oncology Group Study.
    Budd GT, Fleming TR, Bukowski RM, McCracken JD, Rivkin SE, O'Bryan RM, Balcerzak SP, Macdonald JS.
    J Clin Oncol; 1987 Feb; 5(2):272-7. PubMed ID: 3543246
    [Abstract] [Full Text] [Related]

  • 5. Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy.
    Doroshow JH, Multhauf P, Leong L, Margolin K, Litchfield T, Akman S, Carr B, Bertrand M, Goldberg D, Blayney D.
    J Clin Oncol; 1990 Mar; 8(3):491-501. PubMed ID: 2407810
    [Abstract] [Full Text] [Related]

  • 6. 5-fluorouracil and levofolinic acid with or without recombinant interferon-2b in patients with advanced colorectal carcinoma: a randomized multicenter study with stratification for tumor burden and liver involvement by the Southern Italy Oncology Group.
    Colucci G, Maiello E, Gebbia V, Giuliani F, Serravezza G, Lelli G, Leo S, Filippelli G, Nicolella G, Brandi M.
    Cancer; 1999 Feb 01; 85(3):535-45. PubMed ID: 10091727
    [Abstract] [Full Text] [Related]

  • 7. Folinic acid does improve 5-fluorouracil activity in vivo. Results of a phase III study comparing 5-fluorouracil to 5-fluorouracil and folinic acid in advanced colon cancer patients.
    Bobbio-Pallavicini E, Porta C, Moroni M, Spaghi A, Casagranda I, Nastasi G.
    J Chemother; 1993 Feb 01; 5(1):52-5. PubMed ID: 8459266
    [Abstract] [Full Text] [Related]

  • 8. Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patients.
    Bécouarn Y, Gamelin E, Coudert B, Négrier S, Pierga JY, Raoul JL, Provençal J, Rixe O, Krisch C, Germa C, Bekradda M, Mignard D, Mousseau M.
    J Clin Oncol; 2001 Nov 15; 19(22):4195-201. PubMed ID: 11709562
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial.
    Polyzos A, Tsavaris N, Giannopoulos A, Bacoyiannis C, Papadimas V, Kalahanis N, Karatzas G, Kosmas C, Sakelaropoulos N, Archimandritis A, Papachristodoulou A, Kosmidis P.
    Cancer Chemother Pharmacol; 1996 Nov 15; 38(3):292-7. PubMed ID: 8646806
    [Abstract] [Full Text] [Related]

  • 12. Adjuvant radio-chemotherapy in stage II-III rectal cancer with 24-hour infusion of high-dose 5-fluorouracil and folinic acid: evaluation of feasibility.
    Dencausse Y, Sturm J, Hartung G, Dietzler P, Edler L, Bambach M, Wojatschek C, Lindemann H, Qeisser W.
    Onkologie; 2001 Oct 15; 24(5):476-80. PubMed ID: 11694775
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.
    Lokich JJ, Ahlgren JD, Gullo JJ, Philips JA, Fryer JG.
    J Clin Oncol; 1989 Apr 15; 7(4):425-32. PubMed ID: 2926468
    [Abstract] [Full Text] [Related]

  • 15. A randomized study of bolus fluorouracil plus folinic acid versus 21-day fluorouracil infusion alone or in association with cyclophosphamide and mitomycin C in advanced colorectal carcinoma.
    Caudry M, Bonnel C, Floquet A, Marsault C, Quétin P, Pujol J, Maton O, Dujols JP, Caudry Y, Skawinski P.
    Am J Clin Oncol; 1995 Apr 15; 18(2):118-25. PubMed ID: 7900703
    [Abstract] [Full Text] [Related]

  • 16. Fluorouracil and leucovorin with or without interferon alfa-2b in advanced colorectal cancer: analysis of a prospective randomized phase III trial. Hellenic Cooperative Oncology Group.
    Kosmidis PA, Tsavaris N, Skarlos D, Theocharis D, Samantas E, Pavlidis N, Briassoulis E, Fountzilas G.
    J Clin Oncol; 1996 Oct 15; 14(10):2682-7. PubMed ID: 8874327
    [Abstract] [Full Text] [Related]

  • 17. [A randomized comparative study of surgical adjuvant chemotherapy using 5-fluorouracil and dl-leucovorin with CDDP 5-FU and dl-leucovorin for colorectal cancer].
    Okabo S, Arai T, Maruyama S, Lee M, Murase N, Tsubaki M, Endo M, Wada Y, Shimoju K, Sakurazawa K, Sugihara K, Maruyama M, Yabata E, Kawasaki T, Sasaki T.
    Gan To Kagaku Ryoho; 1997 May 15; 24(7):849-54. PubMed ID: 9170524
    [Abstract] [Full Text] [Related]

  • 18. Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial.
    Schmoll HJ, Tabernero J, Maroun J, de Braud F, Price T, Van Cutsem E, Hill M, Hoersch S, Rittweger K, Haller DG.
    J Clin Oncol; 2015 Nov 10; 33(32):3733-40. PubMed ID: 26324362
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C, Bury J, Beauduin M, Herman ML, Vindevoghel A, Lecomte M, Brohée D, Canon JL, Focan-Henrard D, GRECCR Belgium.
    Anticancer Res; 2000 Nov 10; 20(6C):4665-72. PubMed ID: 11205198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.